A landmark head-to-head study reveals that apixaban carries less than half the bleeding risk of rivaroxaban when treating patients with acute venous blood clots.
Most Recent Articles
Improving Treatment Adherence in Major Depressive Disorder via Precision Psychiatry
A breakthrough AI tool developed by Oxford researchers helps doctors pick the right antidepressant for each patient, reducing medication drop-out rates by 40%.
Sustained Perfusion and Differentiation of Multi-Tissue Flaps via Arteriovenous Loops
3D-bioprinted tissue flap featuring an integrated lymphatic system and blood supply could revolutionize reconstructive surgery by eliminating the need for healthy tissue harvesting.
Impact of Long Working Hours on Obesity and Cardiovascular Mortality in U.S. Workers
A new study reveals that working more than 55 hours a week significantly raises the risk of obesity and heart disease, especially when combined with poor dietary habits.
Identifying Novel Microbiome-Derived Biomarkers for Coronary Heart Disease
Researchers have identified nine specific molecules produced by gut microbes that can predict a person's risk of developing coronary heart disease across diverse ethnic populations.